Klaus Strein M.D., Ph.D.
Director and Member of Nomination & Remuneration Committee,BB Biotech AG
|Age||Total Calculated Compensation||This person is connected to 15 board members in 2 different organizations across 4 different industries.|
See Board Relationships
Prof Dr. Klaus Strein served as Chief Technology Officer of BM since 1995 and served as its Head of Pharma since 1997. Prof Dr. Strein joined Boehringer Mannheim (BM) as Head of Cardiovascular Pharmacology from 1979 to 1998. Prof Dr. Strein held top-level research positions at Boehringer Mannheim and Roche. He served as the Head of the Group's Pharma Division. He was responsible for the drug research and development activities resulting in several approved and successfully ...
Seestrasse 16Phone: 41 44 267 67 00
Kusnacht, Zurich CH-8700
Fax: 41 44 267 67 01
Board Members Memberships*
Director and Member of Nomination & Remuneration Committee
University of Heidelberg
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.